Table 1.
Agent | Cells/Tissues | LC3-II | Flux | Mechanisms | Effects | Ref. |
Pimozide | SH-SY5Y cells | ↑ | ↑ | AMPK/ULK1↑ | Tau clearance; Neuronal spine density↑ | 16 |
Pimozide | Mouse hippocampus | ↑ | ↑ | AMPK/ULK1↑ | Tau clearance; Memory improvement | 16 |
Sertindole | SH-SY5Y cells | ↑ | ↑ | ROS↑ | Cell death | 17 |
Olanzapine | SH-SY5Y cells | ↑ | ↑ | ROS↑; ATG mRNA↑ | Apoptotic death upon autophagy inhibition | 18 |
Olanzapine | Mouse hippocampus and frontal cortex | ↑ | n.a. | ATG mRNA↑ | Apoptotic death upon autophagy inhibition | 18 |
Trifluoperazine | SH-SY5Y cells | ↑ | ↑ | TFEB↑; p62 mRNA↑ | n.a. | 19 |
Trifluoperazine | Deyolked zebrafish lysate | ↑ | ↑ | p62 mRNA↑ | DA neurons rescue in PINK1-/- mutants | 19 |
Trifluoperazine | Human neurons in vitro | ↑ | ↑ | n.a. | α-synuclein clearance Neuronal survival↑ | 21 |
Fluphenazine | Rat neurons in vitro | ↑ | ↑ | n.a. | TDP43 clearance; Neuronal survival↑ | 20 |
Methotrimeprazine | Rat neurons in vitro | ↑ | ↑ | n.a. | TDP43 clearanceM Neuronal survival↑ | 20 |
Clozapine | Rat frontal cortex | ↑ | n.a. | AMPK/ULK1↑ | n.a. | 23 |
Clozapine | Rat neurons in vitro | ↓ | ↓ | Autophagosome-lysosome fusion↓ | n.a. | 24 |
Haloperidol | Rat neurons in vitro | ↓ | ↓ | Autophagosome-lysosome fusion↓ | n.a. | 24 |